GFAP and Alzheimer disease: In AD brains, we saw a decrease in neuronal NeuN and an increase in glial fibrillary acidic protein (GFAP) (Fig 3A and Supporting Information Fig 1D) as indicators of neuronal loss and enhanced gliosis, respectively.